Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.31 |
| ▸ | P2RX3 | P56373 | 3/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | PTGES | O14684 | 1/20 | 0.31 |
| ▸ | GALR3 | O60755 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22085498 | 0.95 | POLB (0.35) | SMN1; SMN2LMNAMEN1KMT2ACYP1A2 | |
| SCHEMBL22031827 | 0.95 | CYP1A2 (0.39) | SMN1; SMN2LMNACYP1A2CYP2C19POLB | |
| SCHEMBL22031798 | 0.91 | CYP1A2 (0.36) | SMN1; SMN2LMNACYP1A2CYP2C19POLB | |
| SCHEMBL30484557 | 0.91 | CYP1A2 (0.36) | SMN1; SMN2LMNACYP1A2CYP2C19POLB | |
| SCHEMBL22085491 | 0.91 | POLB (0.35) | LMNACYP1A2CYP2C19POLBP2RX7 | |
| SCHEMBL22085494 | 0.91 | LMNA (0.34) | SMN1; SMN2LMNAMEN1KMT2ACYP1A2 | |
| SCHEMBL22906269 | 0.91 | CCR3 (0.33) | SMN1; SMN2LMNACYP1A2CYP2C19P2RX7 | |
| SCHEMBL30388958 | 0.90 | CYP1A2 (0.33) | SMN1; SMN2LMNAMEN1KMT2ACYP1A2 | |
| SCHEMBL30389030 | 0.90 | HTR2A (0.31) | CYP1A2CYP2C19POLB | |
| SCHEMBL25184309 | 0.90 | SMN1; SMN2 (0.33) | SMN1; SMN2LMNAMEN1KMT2ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12162840-B2 | Herbicidal compositions | SYNGENTA CROP PROTECTION AG (CH) | 2024-12-10 | — | — | US | claimed |
| US-20230301300-A1 | HERBICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2023-09-28 | — | — | US | claimed |
| US-20220119353-A1 | Herbicidal Compositions | SYNGENTA PARTICIPATIONS AG (CH) | 2022-04-21 | — | — | US | claimed |
| US-20230301300-A1 | HERBICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2023-09-28 | — | — | US | disclosed |
| US-20230301300-A1 | HERBICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2023-09-28 | — | — | US | disclosed |
| US-20220119353-A1 | Herbicidal Compositions | SYNGENTA PARTICIPATIONS AG (CH) | 2022-04-21 | — | — | US | disclosed |
| WO-2022033893-A1 | HERBICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2022-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12162840-B2 | Herbicidal compositions | DDT, HPD, PNPO | SMN1; SMN2 4583/4885LMNA 2951/4885MEN1 4581/4885 |
| US-20230301300-A1 | HERBICIDAL COMPOSITIONS | GMDS, DDT, AADAC | SMN1; SMN2 4432/4885LMNA 2970/4885MEN1 4394/4885 |
| US-20220119353-A1 | Herbicidal Compositions | DDT, HPD, PNPO | SMN1; SMN2 4583/4885LMNA 2951/4885MEN1 4581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.